Fresenius Medical Care (NYSE:FMS) Sees Unusually-High Trading Volume

Shares of Fresenius Medical Care AG (NYSE:FMS) saw strong trading volume on Wednesday . 630,950 shares changed hands during trading, an increase of 57% from the previous session’s volume of 403,032 shares.The stock last traded at $19.49 and had previously closed at $19.63.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Truist Financial dropped their price objective on shares of Fresenius Medical Care from $24.00 to $22.00 and set a “hold” rating on the stock in a research note on Wednesday. StockNews.com assumed coverage on shares of Fresenius Medical Care in a research note on Wednesday, July 3rd. They set a “strong-buy” rating on the stock. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Fresenius Medical Care currently has a consensus rating of “Hold” and an average target price of $31.25.

Fresenius Medical Care Trading Down 1.8 %

The firm’s 50 day moving average price is $20.12 and its 200-day moving average price is $20.02. The stock has a market cap of $11.32 billion, a P/E ratio of 21.67, a P/E/G ratio of 1.08 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.50 and a quick ratio of 1.14.

Fresenius Medical Care (NYSE:FMS) last issued its earnings results on Tuesday, May 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.10. The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.15 billion. Fresenius Medical Care had a net margin of 2.48% and a return on equity of 5.29%. As a group, equities research analysts forecast that Fresenius Medical Care AG will post 1.5 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in FMS. Hartford Financial Management Inc. lifted its stake in shares of Fresenius Medical Care by 98.8% in the fourth quarter. Hartford Financial Management Inc. now owns 1,688 shares of the company’s stock worth $35,000 after buying an additional 839 shares in the last quarter. Tower Research Capital LLC TRC raised its holdings in shares of Fresenius Medical Care by 349.3% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,314 shares of the company’s stock valued at $48,000 after purchasing an additional 1,799 shares during the last quarter. GAMMA Investing LLC purchased a new position in shares of Fresenius Medical Care during the fourth quarter valued at approximately $67,000. Assetmark Inc. raised its holdings in shares of Fresenius Medical Care by 169.9% during the fourth quarter. Assetmark Inc. now owns 4,178 shares of the company’s stock valued at $87,000 after purchasing an additional 2,630 shares during the last quarter. Finally, ORG Partners LLC purchased a new position in shares of Fresenius Medical Care during the first quarter valued at approximately $110,000. Institutional investors own 8.25% of the company’s stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.